Explore Products

Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens

  • AcceGen R&D Team
  • Feb 07, 2024
  • 30

You Might Also Like

AcceGen Scroll Top Button